semaglutide news today 2025 fda compounding crackdown The is drawing a harder line on compounded weight loss drug marketing. In the May–June 2026 Tirzepatide causes more weight loss

Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus

Who should NOT take GLP-1 medications

In Germany, Section 34 of the Social Code Book V continues to classify weight management medicines as lifestyle drugs excluded from statutory reimbursement, and that position was upheld again in May 2026 by the Niedersachsen Social Court, which keeps semaglutide reimbursement centered on diabetes rather than obesity treatment

What Is BPC-157 and Why Its Gaining Attention BPC-157, short for Body Protection Compound 157, is a synthetic version of a protein naturally found in the stomach

& Revial, M.-F